KR20230123790A - Cosmetic composition containing bio-cellulose - Google Patents
Cosmetic composition containing bio-cellulose Download PDFInfo
- Publication number
- KR20230123790A KR20230123790A KR1020220021009A KR20220021009A KR20230123790A KR 20230123790 A KR20230123790 A KR 20230123790A KR 1020220021009 A KR1020220021009 A KR 1020220021009A KR 20220021009 A KR20220021009 A KR 20220021009A KR 20230123790 A KR20230123790 A KR 20230123790A
- Authority
- KR
- South Korea
- Prior art keywords
- cosmetic composition
- skin
- mexican
- cellulose
- dextran
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 61
- 239000002537 cosmetic Substances 0.000 title claims abstract description 31
- 229920002678 cellulose Polymers 0.000 title abstract description 24
- 239000001913 cellulose Substances 0.000 title abstract description 24
- 240000005481 Salvia hispanica Species 0.000 claims abstract description 37
- 235000001498 Salvia hispanica Nutrition 0.000 claims abstract description 37
- 239000000284 extract Substances 0.000 claims abstract description 33
- 229920002307 Dextran Polymers 0.000 claims abstract description 24
- 244000215068 Acacia senegal Species 0.000 claims abstract description 21
- 235000010489 acacia gum Nutrition 0.000 claims abstract description 20
- 229920000084 Gum arabic Polymers 0.000 claims abstract description 18
- 239000000205 acacia gum Substances 0.000 claims abstract description 18
- 229920000569 Gum karaya Polymers 0.000 claims abstract description 17
- 235000010494 karaya gum Nutrition 0.000 claims abstract description 17
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 11
- 229920001340 Microbial cellulose Polymers 0.000 claims description 22
- 244000235858 Acetobacter xylinum Species 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 235000002837 Acetobacter xylinum Nutrition 0.000 claims description 7
- 230000037303 wrinkles Effects 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 241000192130 Leuconostoc mesenteroides Species 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 25
- 239000004480 active ingredient Substances 0.000 abstract description 8
- 230000003712 anti-aging effect Effects 0.000 abstract description 7
- 230000001747 exhibiting effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 36
- 238000002360 preparation method Methods 0.000 description 25
- 230000014509 gene expression Effects 0.000 description 24
- 101710128038 Hyaluronan synthase Proteins 0.000 description 23
- 238000009472 formulation Methods 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 102000004190 Enzymes Human genes 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 12
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 12
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 12
- 229940088598 enzyme Drugs 0.000 description 12
- 239000002131 composite material Substances 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 108010003272 Hyaluronate lyase Proteins 0.000 description 10
- 102000001974 Hyaluronidases Human genes 0.000 description 10
- 229960002773 hyaluronidase Drugs 0.000 description 10
- 230000001965 increasing effect Effects 0.000 description 10
- 230000005764 inhibitory process Effects 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 210000002950 fibroblast Anatomy 0.000 description 9
- 108010035532 Collagen Proteins 0.000 description 8
- 102000008186 Collagen Human genes 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 229920001436 collagen Polymers 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- 238000012790 confirmation Methods 0.000 description 7
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 108010050808 Procollagen Proteins 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 229920002674 hyaluronan Polymers 0.000 description 6
- 229960003160 hyaluronic acid Drugs 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 230000036570 collagen biosynthesis Effects 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- 230000009759 skin aging Effects 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 235000006491 Acacia senegal Nutrition 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 102000003918 Hyaluronan Synthases Human genes 0.000 description 3
- 108090000320 Hyaluronan Synthases Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 102000006995 beta-Glucosidase Human genes 0.000 description 3
- 108010047754 beta-Glucosidase Proteins 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 238000002845 discoloration Methods 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- -1 lipid peroxides Chemical class 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- FHYNZKLNCPUNEU-UHFFFAOYSA-N 4-[(3,4-dihydroxyphenyl)methyl]-3-[(4-hydroxyphenyl)methyl]oxolan-2-one Chemical compound C1=CC(O)=CC=C1CC1C(=O)OCC1CC1=CC=C(O)C(O)=C1 FHYNZKLNCPUNEU-UHFFFAOYSA-N 0.000 description 2
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 2
- 229920002749 Bacterial cellulose Polymers 0.000 description 2
- 108010023063 Bacto-peptone Proteins 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000589216 Komagataeibacter hansenii Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000934878 Sterculia Species 0.000 description 2
- 240000001058 Sterculia urens Species 0.000 description 2
- 235000015125 Sterculia urens Nutrition 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 2
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000005016 bacterial cellulose Substances 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 235000020415 coconut juice Nutrition 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000000231 karaya gum Substances 0.000 description 2
- 229940039371 karaya gum Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- YEIPDMVCOQKQHV-UHFFFAOYSA-N 2-(2,5-diphenyltetrazol-1-ium-1-yl)-4,5-dimethyl-1,3-thiazole Chemical compound S1C(C)=C(C)N=C1[N+]1=C(C=2C=CC=CC=2)N=NN1C1=CC=CC=C1 YEIPDMVCOQKQHV-UHFFFAOYSA-N 0.000 description 1
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
- 241000589212 Acetobacter pasteurianus Species 0.000 description 1
- 241000589234 Acetobacter sp. Species 0.000 description 1
- 241000589159 Agrobacterium sp. Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 230000009946 DNA mutation Effects 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 241000032681 Gluconacetobacter Species 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 101150017040 I gene Proteins 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 241000589187 Rhizobium sp. Species 0.000 description 1
- 235000012377 Salvia columbariae var. columbariae Nutrition 0.000 description 1
- 241001037421 Sarcina sp. Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- 239000000809 air pollutant Substances 0.000 description 1
- 231100001243 air pollutant Toxicity 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000014167 chia Nutrition 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 229920002055 compound 48/80 Polymers 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 229940111685 dibasic potassium phosphate Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 239000006014 omega-3 oil Substances 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/591—Mixtures of compounds not provided for by any of the codes A61K2800/592 - A61K2800/596
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 바이오셀룰로오스를 함유하는 화장료 조성물에 관한 것으로서, 구체적으로는 바이오셀룰로오스, 덱스트란, 카라야검, 아라비아검 및 멕시칸치아씨추출물을 유효성분으로 함유하여 안정성이 우수하고, 우수한 피부 보습 및 항노화 활성을 나타내는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing bio-cellulose, and specifically, contains bio-cellulose, dextran, gum karaya, gum arabic, and Mexican chia seed extract as active ingredients, and thus has excellent stability, excellent skin moisturizing and anti-aging It relates to a cosmetic composition exhibiting activity.
Description
본 발명은 바이오셀룰로오스를 함유하는 화장료 조성물에 관한 것으로서, 구체적으로는 바이오셀룰로오스, 덱스트란, 카라야검, 아라비아검 및 멕시칸 치아씨 추출물을 유효성분으로 함유하여 제형 안정성이 우수하고, 우수한 피부 보습 및 항노화 활성을 나타내는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing bio-cellulose, and specifically, contains bio-cellulose, dextran, karaya gum, gum arabic, and Mexican chia seed extract as active ingredients, and thus has excellent formulation stability, excellent skin moisturizing and anti-aging properties. It relates to a cosmetic composition exhibiting aging activity.
피부는 외부로부터 개체를 보호하는 장벽 기능이라는 매우 중요한 역할을 수행한다. 장벽 기능은 화학 물질, 대기오염 물질, 건조한 환경, 자외선 등과 같은 외부로부터의 다양한 자극에 대한 방어와 피부를 통한 체내수분의 과도한 발산을 막는 보호 기능이며, 이러한 보호기능은 각질형성세포로 구성된 각질층(Stratum corneum, horney layer)이 정상적으로 형성되어 있을 경우에만 그 기능을 유지할 수 있다. 피부는 조직학적으로 표피(epidermis), 진피(dermis), 피하지방(subcutis)의 3층으로 구성되어 있는데, 이중 가장 외부에 존재함으로써 피부노화의 측면에서 가장 중요한 역할을 하며, 이에 따라 피부 미용면에서도 가장 집중적인 연구의 대상이 되고 있는 것이 바로 표피이다.The skin plays a very important role as a barrier function that protects the object from the outside. The barrier function is a protection against various stimuli from the outside, such as chemicals, air pollutants, dry environment, and ultraviolet rays, and a protective function that prevents excessive release of water in the body through the skin. Its function can be maintained only when the stratum corneum and horney layer) are normally formed. Skin is histologically composed of three layers: epidermis, dermis, and subcutaneous fat. Being the outermost of these, it plays the most important role in terms of skin aging, and thus in terms of skin beauty. It is the epidermis that has been the subject of the most intensive research.
표피에서도 최외각층인 각질층을 구성하는 성분은 각질세포와 피부지질로서 피부지질은 피부의 장벽 기능을 담당하는데, 이와 같은 피부의 장벽기능은 각질의 세포분열과 분화를 조절하여 외부 유해물질로부터 피부를 보호하고 체내 물질의 유출을 방지하며 피부 수분증발을 방지하는 중요한 기능이라고 할 수 있다.The components that make up the stratum corneum, the outermost layer of the epidermis, are keratinocytes and skin lipids, which are responsible for the barrier function of the skin. It can be said to be an important function to protect, prevent leakage of substances in the body, and prevent evaporation of skin moisture.
그러나 스트레스, 햇빛, 대기오염, 담배 등의 외부환경에 노출되면 활성 산소종이 발생하여, 과산화 지질이 생성되고 콜라겐과 엘라스틴 등의 피부 구성 단백질의 변형이 일어난다. 또한 나이가 들어감에 따라 피부 세포의 활성이 저하되면서 콜라겐과 엘라스틴의 생성능력이 저하되고, 그 결과로 피부의 진피층이 파괴되면서 피부 내부 구조가 약해지고 피부가 얇아지게 되면서, 지방층이 얇은 얼굴에 주름의 형성이 촉진된다. 또한 진피층 내에서 피부보습을 담당하는 점다당질(Glycosaminoglycans, GAGs)이 피부 노화로 인하여 감소하면서 피부가 건조해지며 색소 침착, 탄력 감소 등의 노화 피부의 특징이 나타나게 된다.However, when exposed to external environments such as stress, sunlight, air pollution, and cigarettes, reactive oxygen species are generated, lipid peroxides are generated, and skin constituent proteins such as collagen and elastin are transformed. In addition, as the activity of skin cells declines with age, the ability to produce collagen and elastin decreases. formation is promoted. In addition, as the glycosaminoglycans (GAGs) responsible for skin moisturization in the dermis layer decrease due to skin aging, the skin becomes dry, and the characteristics of aging skin such as pigmentation and loss of elasticity appear.
인간의 피부는 시간이 지나면서 생리적 기능이 저하되면서 노화과정을 겪게 되어 노화의 지표가 피부로 나타난다. 피부 노화 현상 중 주름이 형성되는 원인은 자연적 노화에 의한 주름의 생성과 자외선 노출 광노화에의 한 주름의 생성으로 크게 나눌 수 있으며, 자연적 노화와 광노화에 의한 피부 변화와 관련되어 발견되는 공통적인 현상에 관하여 지금까지의 연구 결과에 의하면 진피 내 주 단백질인 콜라겐과 엘라스틴의 감소 및 변형이 주름의 생성 및 피부의 탄력 저하에 직접적으로 관여하는 것으로 알려져 있다.Human skin undergoes an aging process as its physiological function declines over time, and the indicators of aging appear in the skin. The causes of wrinkle formation among skin aging phenomena can be largely divided into wrinkles caused by natural aging and wrinkles caused by photoaging caused by exposure to ultraviolet rays. According to the research results so far, it is known that the reduction and transformation of collagen and elastin, which are the main proteins in the dermis, are directly involved in the formation of wrinkles and the decrease in skin elasticity.
특히 콜라겐은 피부의 섬유아세포에서 생성되는 주요 기질 단백질로서 콜라겐의 감소가 피부의 주름 형성과 밀접한 연관이 있다는 연구결과가 보고되고 있다. 즉 콜라겐 감소에 영향을 끼치는 자유라디칼들은 피부 콜라겐 등의 결합 조직형성파괴 세포막 기능저해 DNA 변이촉진 단백질 작용변형 세포 간 에너지 전이 신진대사와 관련된 분자들의 변형을 유발하는 것으로 알려져 있으며 이러한 피부노화에 자유라디칼이 관여 한다는 사실은 자유라디칼을 불활성화 시키는 항산화제들을 사용하여 노화과정을 지연시킬 수 있다는 것을 의미한다.In particular, collagen is a major matrix protein produced by fibroblasts of the skin, and research results have been reported that the reduction of collagen is closely related to the formation of wrinkles in the skin. In other words, free radicals that affect collagen reduction are known to induce transformation of molecules related to connective tissue formation such as skin collagen, inhibition of cell membrane function, DNA mutation promotion, protein action, transformation of energy transfer between cells, and metabolism. The fact that it is involved means that the aging process can be delayed by using antioxidants that inactivate free radicals.
특히 노화가 진행됨에 따라 피부의 신진대사가 원활하지 못하므로 피부에 대한 각종 염증 및 알레르기는 가중되게 된다. 또한 건조한 실내 환경, 공해, 자외선, 오용된 화장품이나 세제류 등에 의한 피부 자극에 의해 피부가 민감해져 가는 사람들이 증가하고 있다. 외부자극에 의해 민감해진 피부는 홍반과 같이 가벼운 증상에 그치는 경우도 있지만, 피부 각질층의 수분이 감소하여 피부가 건조해지고 표면이 거칠어지면서 갈라지게 된다. 수분 손실이 되면 각질이 탈락되면서 외부에 노출되기 용이하게 되면서 자극에 대한 염증 및 피부질환이 유발된다. 건조한 피부는 면역기능이 약화되어 가려움증, 아토피 피부염 등의 알러지가 유발되기 쉬워진다. 그러므로 피부의 수분 손실을 방지하는 것은 중요하다.In particular, since the metabolism of the skin is not smooth as aging progresses, various inflammations and allergies to the skin are aggravated. In addition, the number of people whose skin becomes sensitive due to skin irritation caused by a dry indoor environment, pollution, ultraviolet rays, and misused cosmetics or detergents is increasing. Skin that has become sensitive due to external stimuli may only have mild symptoms such as erythema, but the moisture in the stratum corneum of the skin decreases, resulting in dry skin and roughened surface, resulting in cracks. When moisture is lost, dead skin cells are easily exposed to the outside as they are eliminated, causing inflammation and skin diseases due to irritation. Dry skin weakens the immune function, making it easy to cause allergies such as itching and atopic dermatitis. Therefore, it is important to prevent water loss from the skin.
생활수준 향상에 따라 피부노화와 같은 미용과 건강에 관한 관심이 급증하는 가운데 기능성 화장품을 개발하려는 연구가 활발해지고 있으며, 식품의약품안전청의 기능성화장품 고시 품목으로서 주름개선 소재로 대표적으로 사용되는 레티놀(비타민 A), AHA(a-hydroxy acid), 아데노신 등은 콜라겐의 합성을 증가시키는 물질로 많이 사용되고 있지만 빛과 열에 불안정하고 피부에 자극이 있는 것으로 알려져 있다.As interest in beauty and health, such as skin aging, is rapidly increasing with the improvement of living standards, research to develop functional cosmetics is being actively conducted, and retinol (vitamin A), AHA (a-hydroxy acid), adenosine, etc. are widely used as substances that increase the synthesis of collagen, but are known to be unstable to light and heat and cause irritation to the skin.
셀룰로오스, 키토산, 다당류 폴리머와 같은 천연고분자(natural polymer)는 생체적합성, 생분해성 성질을 가진 피부 친화적 물질이다. 그중에서도 셀룰로오스는 지구상에서 가장 풍부한 바이오 고분자일 뿐만 아니라, 그 종류에 따라 각기 고유한 물성을 가지기 때문에 다양한 용도로 사용될 수 있다. Natural polymers such as cellulose, chitosan, and polysaccharide polymers are skin-friendly materials with biocompatibility and biodegradability. Among them, cellulose is not only the most abundant biopolymer on earth, but also can be used for various purposes because it has unique physical properties depending on its type.
일반적으로 화장품에 사용되는 셀룰로오스로는 수십 마이크로미터 크기를 가지는 셀룰로오스 마이크로 입자, 카복시메틸 셀룰로오스(carboxymethyl cellulose, CMC)와 하이드록시에틸 셀룰로오스(hydroxyethyl cellulose, HEC)와 같은 셀룰로오스 유도체, 그리고 바이오셀룰로오스가 있다.Cellulose commonly used in cosmetics includes cellulose microparticles having a size of several tens of micrometers, cellulose derivatives such as carboxymethyl cellulose (CMC) and hydroxyethyl cellulose (HEC), and biocellulose.
바이오셀룰로오스(bio-cellulose)는 Acetobacter xylinum(A. xylinum) 등의 미생물로부터 직접 합성되는 바이오 폴리머로서, 미생물 셀룰로오스, 박테리아 셀룰로오스(bacterial cellulose, BC)라고도 불린다. 바이오셀룰로오스는 식물유래 셀룰로오스에 비해 높은 물리적 강도를 가지고, 수분 흡수 및 유지 능력이 우수하며, 균일한 섬유 네트워크 형성이 가능하다는 다양한 장점을 가진다. Bio-cellulose is a bio-polymer synthesized directly from microorganisms such as Acetobacter xylinum (A. xylinum), and is also called microbial cellulose or bacterial cellulose (BC). Compared to plant-derived cellulose, bio-cellulose has various advantages such as high physical strength, excellent ability to absorb and retain moisture, and formation of a uniform fiber network.
이러한 장점으로 인해 마스크 시트로 주목받고 있으나, 주로 시트 형태로 제조되기 때문에 다양한 제형으로의 적용에 어려운 점이 있다. 또한, 분말 형태로 적용하는 경우에도 수분산성이 낮아 침전이 발생하는 등의 이유로 인해 이용에 어려움이 있었다.Due to these advantages, it is attracting attention as a mask sheet, but since it is mainly manufactured in a sheet form, it is difficult to apply it to various formulations. In addition, even when applied in the form of powder, it was difficult to use due to reasons such as low water dispersibility and occurrence of precipitation.
본 발명자들은 항노화 화장료의 개발에 관한 연구 중에 바이오셀룰로오스의 우수한 피부개선활성에 주목하고 이를 화장료로 적용하기 위하여 연구하여 왔으며, 다양한 성분들을 적용하여 안정성 시험을 하였으며, 그 결과 바이오셀룰로오스와 함께 특정한 비율로 덱스트란, 카라야검, 아라비아검 및 멕시칸 치아씨 추출물을 혼합 사용하는 경우에 제형 내에서의 안정성이 개선되고, 우수한 피부보습 및 항노화 활성을 나타내는 것을 발견하여 본 발명을 완성하였다.The present inventors have paid attention to the excellent skin improvement activity of bio-cellulose during research on the development of anti-aging cosmetics and have studied to apply it as a cosmetic, and tested stability by applying various ingredients. As a result, a specific ratio with bio-cellulose The present invention was completed by finding that when rhodextran, gum karaya, gum arabic, and Mexican chia seed extract were mixed and used, stability in the formulation was improved and excellent skin moisturizing and anti-aging activities were exhibited.
본 발명은 바이오셀룰로오스, 덱스트란, 카라야검, 아라비아검 및 멕시칸 치아씨 추출물을 함유하여 안정성이 개선되고, 우수한 피부보습 및 항노화 효능을 나타내는 화장료 조성물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a cosmetic composition containing biocellulose, dextran, gum karaya, gum arabic, and Mexican chia seed extract to improve stability and exhibit excellent skin moisturizing and anti-aging effects.
상기 목적을 달성하기 위하여 본 발명에 따르면, 바이오셀룰로오스, 덱스트란, 카라야검, 아라비아검 및 멕시칸 치아씨 추출물을 조성물 전체 중량에 대하여 0.1~10 중량% 함유하는 화장료 조성물이 제공된다.According to the present invention to achieve the above object, a cosmetic composition containing 0.1 to 10% by weight of biocellulose, dextran, gum karaya, gum arabic, and Mexican chia seed extract based on the total weight of the composition is provided.
바람직하게는 상기 바이오셀룰로오스는 글루콘아세토박터 자일리누스(Gluconacetobacter xylinus) 발효물을 여과 추출하여 제조된 것임을 특징으로 한다. 상기 덱스트란은 류코노스톡 메센테로이데스(Leuconostoc mesenteroides)의 발효물을 여과하여 제조된 것임을 특징으로 한다.Preferably, the bio-cellulose is characterized in that it is prepared by filtering and extracting the fermented product of Gluconacetobacter xylinus. The dextran is characterized in that it is prepared by filtering the fermentation product of Leuconostoc mesenteroides.
바람직하게는, 상기 멕시칸 치아씨 추출물은 멕시칸 치아씨 추출물을 가수분해효소, 더욱 바람직하게는 β-글루코시다아제로 처리하여 제조되는 것임을 특징으로 한다.Preferably, the Mexican chia seed extract is characterized in that it is prepared by treating the Mexican chia seed extract with a hydrolase, more preferably β-glucosidase.
바람직하게는 상기 바이오셀룰로오스, 덱스트란, 카라야검 및 아라비아검은 각각 1~2:1~2:1~2:1~2의 중량비율로 함유되며, 상기 바이오셀룰로오스, 덱스트란, 카라야검 및 아라비아검의 혼합물은 멕시칸치아씨추출물과는 각각 1~5:1~5의 중량비율로 함유된다.Preferably, the biocellulose, dextran, gum karaya, and gum arabic are contained in a weight ratio of 1 to 2:1 to 2:1 to 2:1 to 2, respectively, and the biocellulose, dextran, gum karaya, and gum arabic The mixture is contained in a weight ratio of 1 to 5: 1 to 5 with Mexican chia seed extract, respectively.
상기 화장료 조성물은 피부 보습용임 및 피부 주름개선용임을 특징으로 한다.The cosmetic composition is characterized in that it is for moisturizing the skin and improving skin wrinkles.
바이오셀룰로오스, 덱스트란, 카라야검, 아라비아검 및 멕시칸치아씨추출물을 조성물을 함유하는 본 발명 화장료 조성물은 제형 안정성이 우수하며 그 상승작용에 의하여 우수한 피부보습 및 항노화 효과를 나타낸다.The cosmetic composition of the present invention containing biocellulose, dextran, gum karaya, gum arabic, and Mexican chia seed extract has excellent formulation stability and exhibits excellent skin moisturizing and anti-aging effects due to its synergistic action.
이하 본 발명을 더욱 상세히 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명은 우수한 보습활성을 가지는 바이오셀룰로오스의 안정성을 개선하고 다른 활성성분들과의 혼합사용을 통하여 보습활성이 우수할 뿐만 아니라 피부 주름개선 등의 항노화 활성이 우수한 화장료 조성물을 제공하는 것을 특징으로 한다.The present invention is characterized by improving the stability of bio-cellulose having excellent moisturizing activity and providing a cosmetic composition having excellent anti-aging activity such as skin wrinkle improvement as well as excellent moisturizing activity through mixed use with other active ingredients. do.
본 발명의 화장료 조성물에 유효 성분으로 포함되는 바이오셀룰로오스는 당업계의 통상적인 방법에 의하여 수득될 수 있으며 그 제조방법은 특별히 한정되지 아니한다. 본 발명의 바이오셀룰로오스는 글루콘아세토박터 자일리누스(Gluconacetobacter xylinus, Acetobacter xylinum) 발효물을 여과 추출하여 제조되는 것이 바람직하나, 아세토박터 파스테우리아누스(A. pasteurinanus), 아세토박터 한세니(A. hansenii) 등의 다른 아세토박터 속(Acetobacter sp.) 미생물 뿐 아니라 아그로박테리움 속(Agrobacterium sp.), 리조비움 속(Rhizobium sp.), 슈도모나스 속(Pseudomonas sp.), 사르시나(Sarcina sp.) 속 미생물 등도 사용할 수 있다. 접종되는 미생물의 탄소원은 당업계에 잘 알려져 있으며, 따라서 당업계에 알려진 임의의 것을 사용할 수 있는데, 통상은 올리고당, 유당, 포도당, 과당, 설탕, 당밀, 덱스트로스, 이들의 혼합물 등이 사용될 수 있다. 또한 식물 등의 다양한 천연 추출물을 배양액과 혼합하여 피부 미용 기능성 성분을 향상시키거나 착향 및/또는 착색 효과를 부여할 수 있다.Bio-cellulose included as an active ingredient in the cosmetic composition of the present invention can be obtained by a conventional method in the art, and its preparation method is not particularly limited. The bio-cellulose of the present invention is preferably prepared by filtering and extracting the fermented product of Gluconacetobacter xylinus (Acetobacter xylinus), A. pasteurianus ( A. pasteurinanus ), Acetobacter hansenii ( A. hansenii ), as well as other Acetobacter sp. microorganisms such as Agrobacterium sp. , Rhizobium sp. , Pseudomonas sp. , Sarcina sp. Genus microorganisms and the like can also be used. The carbon source of the microorganism to be inoculated is well known in the art, and therefore, any material known in the art may be used, usually oligosaccharide, lactose, glucose, fructose, sucrose, molasses, dextrose, mixtures thereof, and the like may be used. . In addition, various natural extracts such as plants may be mixed with the culture medium to improve skin cosmetic functional ingredients or impart flavoring and/or coloring effects.
본 발명 화장료 조성물의 다른 유효성분으로서 포함되는 덱스트란(Dextran)은 류코노스톡(Leuconostoc) 균주에 의하여 생산되는 천연 고분자로 화장품 제형에서 점증제, 결합제, 벌킹제로 사용된다. 당업계의 통상적인 방법에 의하여 수득될 수 있으며 그 제조방법은 특별히 한정되지 아니한다. 본 발명에서는 바람직하게는 류코노스톡 메센테로이데스(Leuconostoc mesenteroides)의 발효물을 여과하여 제조된다. Dextran, which is included as another active ingredient of the cosmetic composition of the present invention, is a natural polymer produced by Leuconostoc strains and is used as a thickener, binder, and bulking agent in cosmetic formulations. It can be obtained by a conventional method in the art, and the manufacturing method is not particularly limited. In the present invention, it is preferably prepared by filtering the fermented product of Leuconostoc mesenteroides .
본 발명 화장료 조성물의 다른 유효성분인 카라야검(Karaya gum)은 스터큘리아 우렌즈 록스버그(Sterculia urens Roxburgh)의 검상 분비물을 건조한 것으로, 갈락토스, 람노스 및 갈락튜론산을 주성분으로 하는 다당류로서 화장품에서 유화제, 증점제, 안정제 등으로 사용된다. 1%(w/v) 수용액의 pH는 4.5-5.0이다.Karaya gum, another active ingredient of the cosmetic composition of the present invention, is dried gummy secretion of Sterculia urens Roxburgh, and is a polysaccharide mainly composed of galactose, rhamnose and galacturonic acid. It is used as an emulsifier, thickener, stabilizer, etc. The pH of a 1% (w/v) aqueous solution is 4.5-5.0.
본 발명 화장료 조성물의 유효성분인 아라비아검(Acacia Senegal Gum)은 아카시아 세네갈 검으로도 명명되며, 분쇄하지 않은 것은 백색-황백색의 다양한 크기를 가진 둥근 모양의 덩어리이거나 각을 가지는 조각 또는 백-황백색의 박편, 과립 또는 분말상이다. 아라비아검은 콩과 아라비아고무나무(Acacia senegal WILLDENOW) 또는 그 밖의 동속 식물의 분비액을 건조시킨 것이거나 또는 이를 탈염하여 얻어지는 것으로서 주성분은 다당류이다. 물을 가하면 서서히 용해되어 산성을 나타내는데 50% 수용액까지 맛이 없는 농후한 점성액이 되며 시간이 경과함에 따라 점도가 저하된다. 특히, 넓은 pH의 범위에서 안정된 유화물을 얻을 수 있고 식염 등의 전해질이 있어도 o/w 유화가 가능하다.Gum arabic (Acacia Senegal Gum), which is an active ingredient of the cosmetic composition of the present invention, is also named acacia Senegal gum, and what is not pulverized is white-yellowish-white round lumps of various sizes, angular pieces, or white-yellowish-white It is in the form of flakes, granules or powder. It is obtained by drying or desalting the secretion of black arabic beans, Acacia senegal WILLDENOW or other plants of the same genus, and the main component is polysaccharide. When water is added, it dissolves slowly and shows acidity. It becomes a tasteless thick viscous liquid up to 50% aqueous solution, and the viscosity decreases over time. In particular, stable emulsions can be obtained in a wide range of pH, and o/w emulsification is possible even in the presence of electrolytes such as table salt.
멕시칸 치아씨(Salvia hispanica seed)는 치아(chia, Salvia hispanica)의 씨앗으로, 치아는 멕시코 중남부와 과테말라에 자생하는 박하과에 속하는 현화식물의 종이다. 씨앗을 수확하기 위해 경작되며 남아메리카, 멕시코 서부, 미국 남서부 지역에서 수세기에 걸쳐 음식과 기능성 식품으로 흔히 쓰이고 있다. 멕시칸 치아씨는 친수성 성질을 갖고 있으며 약 12배의 수분을 흡수하는 능력이 있다. 멕시칸 치아씨 100 g당 영양성분을 살펴보면 탄수화물이 약 42 g, 지방 30 g, 단백질 16 g, 기타 미네랄 성분을 포함하고 있으며, 리놀렌산과 같은 오메가 3 지방산이 약 25~30% 함유하고 있다. 또한 멕시칸 치아씨는 밀, 옥수수, 쌀, 귀리 등 다른 곡식과 달리 비교적 높은 함량의 단백질을 함유하고 있다.Mexican chia seeds (Salvia hispanica seeds) are the seeds of chia (Salvia hispanica), which is a species of flowering plant belonging to the mint family native to southern central Mexico and Guatemala. It is cultivated for its seeds and has been a common food and nutraceutical for centuries in South America, western Mexico, and the American Southwest. Mexican chia seeds have hydrophilic properties and are capable of absorbing about 12 times as much water. Looking at the nutritional content per 100 g of Mexican chia seeds, it contains about 42 g of carbohydrates, 30 g of fat, 16 g of protein, and other minerals, and contains about 25-30% of omega-3 fatty acids such as linolenic acid. In addition, Mexican chia seeds contain a relatively high protein content, unlike other grains such as wheat, corn, rice, and oats.
본 발명에 따르면 바이오셀룰로오스(bio-cellulose), 덱스트란(dextran), 카라야검, 아라비아검 및 멕시칸 치아씨 추출물을 조성물 전체 중량에 대하여 0.1~10 중량% 함유하는 화장료 조성물이 제공된다.According to the present invention, a cosmetic composition containing 0.1 to 10% by weight of bio-cellulose, dextran, gum karaya, gum arabic, and Mexican chia seed extract based on the total weight of the composition is provided.
바람직하게는, 상기 바이오셀룰로오스는 글루콘아세토박터 자일리누스(Gluconacetobacter xylinus) 발효물을 여과 추출하여 제조된 것임을 특징으로 한다. 또한, 상기 덱스트란은 류코노스톡 메센테로이데스(Leuconostoc mesenteroides)의 발효물을 여과하여 제조된 것임을 특징으로 한다.Preferably, the bio-cellulose is produced by filtration and extraction of fermented product of Gluconacetobacter xylinus . In addition, the dextran is characterized in that it is prepared by filtering the fermentation product of Leuconostoc mesenteroides .
상기 멕시칸 치아씨 추출물은 멕시칸 치아씨(Salvia hispanica Seed) 추출물을 가수분해효소, 더욱 바람직하게는 β-글루코시다아제로 처리하여 제조되는 것이다. 이 경우에 더욱 우수한 보습 및 주름개선활성을 나타낸다.The Mexican chia seed extract is prepared by treating Salvia hispanica Seed extract with a hydrolase, more preferably β-glucosidase. In this case, it exhibits more excellent moisturizing and anti-wrinkle activity.
상기 바이오셀룰로오스, 덱스트란, 카라야검 및 아라비아검은 각각 1~2:1~2:1~2:1~2의 중량비율로 함유되며, 각각 2:1:1:2의 중량비율로 함유되는 경우에 바이오셀룰로오스의 안정성 및 피부 보습, 주름개선활성이 더욱 우수하므로 바람직하다. The biocellulose, dextran, gum karaya, and gum arabic are contained in a weight ratio of 1 to 2: 1 to 2: 1 to 2: 1 to 2, respectively, and are contained in a weight ratio of 2: 1: 1: 2, respectively It is preferable because it has more excellent stability, skin moisturizing, and anti-wrinkle activity of bio-cellulose.
또한, 상기 바이오셀룰로오스, 덱스트란, 카라야검 및 아라비아검의 혼합물은 다른 유효성분인 멕시칸 치아씨 추출물과는 각각 1~5:1~5의 중량비율로, 더욱 바람직하게는 1:5의 중량비율로 함유된다.In addition, the mixture of biocellulose, dextran, gum karaya, and gum arabic has a weight ratio of 1 to 5: 1 to 5, more preferably 1: 5, respectively, with the Mexican chia seed extract, which is another active ingredient. is contained with
상기의 구성 및 비율로 함유되는 경우에 제형 내에서의 바이오셀룰로오스의 안정성이 우수한 것을 확인하였다(시험예 7). 또한 상기 화장료 조성물은 우수한 히알루론산 합성효소(HAS-3)의 발현 증가 효과(시험예 3), 히알루로니다제의 활성 억제 효과(시험예 4), MMP-1 생성억제효과(시험예 5), 콜라겐 생합성 촉진 효과(시험예 6)를 나타내었다.It was confirmed that the stability of biocellulose in the formulation was excellent when it was contained in the above composition and ratio (Test Example 7). In addition, the cosmetic composition has an excellent hyaluronic acid synthase (HAS-3) expression increasing effect (Test Example 3), hyaluronidase activity inhibitory effect (Test Example 4), MMP-1 production inhibitory effect (Test Example 5) , showed collagen biosynthesis promoting effect (Test Example 6).
본 발명의 화장료 조성물은 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 그 예로는 화장수, 크림, 에센스, 클렌징 폼, 클렌징 워터, 팩, 바디 로션, 바디 오일, 바디 젤, 샴푸, 린스, 헤어 컨디셔너, 헤어 젤, 화운데이션, 립스틱, 마스카라, 메이크업 베이스 등을 들 수 있다. The cosmetic composition of the present invention can be prepared in any formulation that is conventionally prepared, and examples thereof include lotion, cream, essence, cleansing foam, cleansing water, pack, body lotion, body oil, body gel, shampoo, rinse, and hair. Conditioner, hair gel, foundation, lipstick, mascara, makeup base, etc. may be mentioned.
[실시예][Example]
이하, 하기의 실시예와 시험예들을 통하여 본 발명을 상세하게 설명하지만, 본 발명이 이 예들에 의하여 한정되는 것은 아니다. Hereinafter, the present invention will be described in detail through the following examples and test examples, but the present invention is not limited by these examples.
제조예 1: 바이오셀룰로오스의 제조Preparation Example 1: Preparation of bio-cellulose
하기 표 1과 같은 조성으로 영양 배지(1L)를 멸균 제조하였다. A nutrient medium (1L) was sterilized with the composition shown in Table 1 below.
멸균된 배지에 글루콘아세토박터 자일리누스(Gluconacetobacter xylinus) 균주를 OD600 = 0.1의 양으로 접종하고 30℃ 항온 배양기에서 10일간 정치 배양하였다. 상기 글루콘아세토박터 균주로부터 생산된 미생물 셀룰로오스가 포함된 정치 배양액을 3,000rpm에서 30분간 원심분리하여 상등액을 제거하고, 0.3N NaOH 용액을 넣고 100℃에서 10분간 중탕하여 미생물 셀룰로오스에 섞여 있는 균주를 NaOH 용액에 녹였다. 4,000 rpm에서 20분간 원심분리하여 NaOH 용액을 제거한 후 5% 초산용액을 넣고 세척하였다. 4,000 rpm에서 20분간 원심분리하여 초산용액을 제거한 후 충분한 양의 증류수로 세척하여 중화시킨 후 65℃ 오븐에서 무게 변화가 없을 때까지 건조하였다. 이 결과 얻은 셀룰로오스를 분쇄하여 바이오셀룰로우스 분말을 제조하였다.Gluconacetobacter xylinus strain was inoculated into a sterilized medium in an amount of OD600 = 0.1, and then cultured for 10 days in a constant temperature incubator at 30°C. The stationary culture solution containing the microbial cellulose produced from the Gluconacetobacter strain was centrifuged at 3,000 rpm for 30 minutes to remove the supernatant, and a 0.3N NaOH solution was added thereto. dissolved in NaOH solution. After removing the NaOH solution by centrifugation at 4,000 rpm for 20 minutes, a 5% acetic acid solution was added and washed. After removing the acetic acid solution by centrifugation at 4,000 rpm for 20 minutes, it was neutralized by washing with a sufficient amount of distilled water and dried in an oven at 65 ° C until there was no change in weight. The resulting cellulose was pulverized to prepare biocellulose powder.
제조예 2: 덱스트란의 제조Preparation Example 2: Preparation of Dextran
하기 표 2의 조성의 영양 배지(1L)를 멸균 제조하였다. Nutrient medium (1L) of the composition shown in Table 2 below was sterilized.
멸균된 배지에 류코노스톡 메센테로이데스(Leuconostoc mesenteroides)를 OD600 = 0.1의 양으로 접종하여 접종하고 30℃ 항온 배양기에서 10일간 정치 배양하였다. 상기 정치 배양액을 3,000rpm에서 30분간 원심분리하여 상등액을 제거하고 건조하여 덱스트란을 제조하였다.Leuconostoc mesenteroides was inoculated into a sterilized medium in an amount of OD600 = 0.1 and inoculated and cultured for 10 days in a constant temperature incubator at 30 ° C. The stationary culture solution was centrifuged at 3,000 rpm for 30 minutes to remove the supernatant and dried to prepare dextran.
실시예 1~5: 바이오셀룰로오스, 덱스트란, 카라야검 및 아라비아검 혼합물의 제조Examples 1 to 5: Preparation of mixtures of biocellulose, dextran, gum karaya and gum arabic
상기 제조예 1, 2에서 제조된 바이오셀룰로오스, 덱스트란과, 카라야검(Naturganic(네이처가닉), 인도 산), 아라비아검(ES식품원료, 프랑스 산)을 하기 표 3의 중량비로 혼합하여 혼합물(100g)을 제조하였다.Biocellulose and dextran prepared in Preparation Examples 1 and 2, gum karaya (Naturganic, produced in India), and gum arabic (ES food raw material, produced in France) were mixed in the weight ratio shown in Table 3 below to obtain a mixture. (100 g) was prepared.
제조예 3: 멕시칸치아씨 추출물의 제조 Preparation Example 3: Preparation of Mexican Chia Seed Extract
정제수로 세적한 후 건조시킨 멕시칸 치아씨 1Kg에 추출용매로서 70% 함수 에탄올 5배 중량을 넣고 냉각 콘덴서가 달린 추출기(Cosmos-660, 경서기계)에서 80~100℃로 가열하여 2 시간씩 총 3회 추출하였다.After washing with purified water, add 5 times the weight of 70% water-containing ethanol as an extraction solvent to 1Kg of dried Mexican chia seeds and heat them at 80-100℃ in an extractor with a cooling condenser (Cosmos-660, Gyeongseo Machinery) for 2 hours in total. Extracted twice.
위의 방법으로 추출한 뒤 3일간 실온에서 방치하여 침전물을 300메쉬 여과지로 여과하고, 침전물을 에드벤텍 5번 여과지와 와트만 GFC 150mm 여과지로 2번 여과하였다. 그리고 감압 농축기(Coolace CCA-1100, EYELA)를 이용하여 40℃~50℃의 온도에서 농축한 후 스프레이 드라이어(B-290, BUCHI사)를 이용하여 인렛(Inlet) 온도 180℃, 흡입기(Aspirator) 효율 100%(35㎤/시간), 펌프(Pump) 효율 25%(7.5㎖/분), 노즐클리너 4(Nozzle Cleaner 4) 및 유량계(Rotameter):30㎜(357리터/시간)의 조건으로 건조시켜 표제의 추출분말 100g을 얻었다.After extraction by the above method, the precipitate was left at room temperature for 3 days, and the precipitate was filtered with 300 mesh filter paper, and the precipitate was filtered twice with Edvantech No. 5 filter paper and Whatman GFC 150mm filter paper. After concentrating at a temperature of 40℃~50℃ using a vacuum concentrator (Coolace CCA-1100, EYELA), use a spray dryer (B-290, BUCHI) at an inlet temperature of 180℃ and an aspirator. Drying under conditions of 100% efficiency (35cm3/hour), 25% pump efficiency (7.5ml/minute), Nozzle Cleaner 4 and Rotameter: 30mm (357 liters/hour) to obtain 100 g of the titled extracted powder.
제조예 4: 효소처리 멕시칸 치아씨 추출물의 제조 Preparation Example 4: Preparation of enzyme-treated Mexican chia seed extract
상기 제조예 3에서 제조된 추출분말 10g을 아세테이트 버퍼(acetate buffer, pH 4.0) 500ml, β-글루코시다아제 효소 1ml을 넣어 50℃에서 20시간 동안 반응시켰다. 다음으로 95℃로 30분간 가온하여 효소 반응을 완료한 후 반응물을 진공 농축하였다. 농축물은 60℃에서 30시간 건조하였다. 위의 방법으로 추출한 뒤 3일간 실온에서 방치하여 침전물을 300메쉬 여과지로 여과하고, 침전물을 에드벤텍 5번 여과지와 와트만 GFC 150mm 여과지로 2번 여과하였다. 그리고 감압 농축기(Coolace CCA-1100, EYELA)를 이용하여 40℃~50℃의 온도에서 농축한 후 스프레이 드라이어(B-290, BUCHI사)를 이용하여 인렛(Inlet) 온도 180℃, 흡입기(Aspirator) 효율 100%(35㎤/시간), 펌프(Pump) 효율 25%(7.5㎖/분), 노즐클리너 4(Nozzle Cleaner 4) 및 유량계Rotameter): 30㎜(357리터/시간)의 조건으로 건조시켜 효소처리 멕시칸 치아씨 추출물을 제조하였다.10 g of the extracted powder prepared in Preparation Example 3 was added to 500 ml of acetate buffer (pH 4.0) and 1 ml of β-glucosidase enzyme and reacted at 50° C. for 20 hours. Next, after heating to 95 ℃ for 30 minutes to complete the enzymatic reaction, the reactant was concentrated in vacuo. The concentrate was dried at 60 °C for 30 hours. After extraction by the above method, the precipitate was left at room temperature for 3 days, and the precipitate was filtered with 300 mesh filter paper, and the precipitate was filtered twice with Edvantech No. 5 filter paper and Whatman GFC 150mm filter paper. After concentrating at a temperature of 40℃~50℃ using a vacuum concentrator (Coolace CCA-1100, EYELA), use a spray dryer (B-290, BUCHI) at an inlet temperature of 180℃ and an aspirator. Efficiency 100% (35cm3/hour), Pump efficiency 25% (7.5ml/min), Nozzle Cleaner 4 and Flowmeter Rotameter: Dry under conditions of 30mm (357 liters/hour) An enzyme-treated Mexican chia seed extract was prepared.
시험예 1 :히알루론산 합성효소(HAS-3)의 발현 증가효과 확인Test Example 1: Confirmation of the effect of increasing the expression of hyaluronic acid synthase (HAS-3)
인간 섬유아세포 NHDF를 10% FBS가 첨가된 DMDM 배지를 이용하여 5×105 cell/well로 조절한 후 12 well plate에 접종하고 18시간 동안 배양하였다. 배양한 뒤 상기 실시예 1~5, 제조예 4의 시료를 처리하고 24시간 동안 배양하였다. 배양된 세포에서 RNA를 추출하여 Reverse transcription polymerase chain reaction(RT-PCR)을 통해 Hyaluronan Synthase-3(HAS-3)의 발현 증가율을 확인하였다. HAS-3 발현 증가율은 하기식에 의해 산출되었고, 그 결과는 표 4에 나타내었다. Human fibroblast NHDF was adjusted to 5×10 5 cells/well using DMDM medium supplemented with 10% FBS, and then inoculated into a 12 well plate and cultured for 18 hours. After culturing, the samples of Examples 1 to 5 and Preparation Example 4 were treated and cultured for 24 hours. RNA was extracted from the cultured cells and the increase in expression of Hyaluronan Synthase-3 (HAS-3) was confirmed through reverse transcription polymerase chain reaction (RT-PCR). The HAS-3 expression increase rate was calculated by the following formula, and the results are shown in Table 4.
HAS-3 발현증가율(%)=(시료 HAS-3 발현양/대조군 HAS-3 발현양) × 100HAS-3 expression increase rate (%) = (sample HAS-3 expression amount / control group HAS-3 expression amount) × 100
혼합물 시료 중에서 실시예 5의 시료에서 가장 우수한 히알루론산 합성효소(HAS-3)의 발현 증가효과를 확인할 수 있었다.Among the mixture samples, it was confirmed that the sample of Example 5 had the most excellent effect of increasing the expression of hyaluronic acid synthase (HAS-3).
실시예 6~8: 바이오셀룰로오스, 덱스트란, 카라야검 및 아라비아검 혼합물과 멕시칸치아씨 추출물의 복합물 제조Examples 6 to 8: Preparation of Complexes of Biocellulose, Dextran, Karaya Gum and Arabic Gum Mixtures and Mexican Chia Seed Extract
가장 우수한 히알루론산 합성효소 발현 증가효과를 나타내는 상기 실시예 5의 혼합물과 상기 제조예 4의 효소처리 멕시칸 치아씨 추출물을 하기 표 5의 중량비율로 혼합하여 복합물을 제조하였다.A composite was prepared by mixing the mixture of Example 5, which exhibits the highest hyaluronic acid synthase expression increasing effect, and the enzyme-treated Mexican chia seed extract of Preparation Example 4 in a weight ratio shown in Table 5 below.
비교예 1: 바이오셀룰로오스, 덱스트란, 카라야검 및 아라비아검 혼합물과 멕시칸치아씨 추출물의 복합물 제조Comparative Example 1: Preparation of Complex of Biocellulose, Dextran, Karaya Gum and Arabic Gum Mixture and Mexican Chia Seed Extract
가장 우수한 히알루론산 합성효소 발현 증가효과를 나타내는 상기 실시예 5의 혼합물과 상기 제조예 3의 멕시칸 치아씨 추출물을 각각 1:5의 중량비율로 혼합하여 복합물을 제조하였다.A composite was prepared by mixing the mixture of Example 5 and the Mexican chia seed extract of Preparation Example 3 at a weight ratio of 1:5, which exhibited the highest hyaluronic acid synthase expression increasing effect.
시험예 2: 세포 독성 여부 확인 Test Example 2: Confirmation of cytotoxicity
세포 독성 여부를 확인하기 위해 섬유아세포를 10% FBS를 첨가한 IMDM 배지에 5×105의 세포 농도로 접종하여, 37℃ 5% CO2 배양기에서 24시간 동안 배양하였다. 배양 후 배지를 제거하고 상기 실시예에서 제조한 추출물을 시료농도가 0.5%, 1.5%, 2%가 되도록 디메틸설폭시드에 희석하여 제조한 희석용액을 처리하여 24시간 배양한 후에 MTT(3-[4,5-dimethylthiazol-2yl] - 2,5-diphenyltetrazoliumboromide, Sigma, U.S.A.)용액을 각 well에 100㎖씩 첨가한 후 (3㎎/㎖) 4시간 동안 더 배양하였다. 이후 상층액을 제거하고, 150㎕의 디메틸 설폭시드를 첨가한 후, 30분간 shaking하여 생성된 formazan을 녹여 multimicroplate reader(Molecular device Spectra max190)를 이용하여 540nm에서 흡광도를 측정하였다. 세포생존율은 아래의 식에 따라 계산하였으며 그 결과는 하기의 표 6에 나타내었다.In order to confirm cytotoxicity, fibroblasts were inoculated at a cell concentration of 5×10 5 in IMDM medium supplemented with 10% FBS, and cultured for 24 hours in a 37° C. 5% CO 2 incubator. [ 4,5-dimethylthiazol-2yl] -2,5-diphenyltetrazolium boromide, Sigma, USA) solution was added to each well at 100 ml (3 mg/ml), followed by further incubation for 4 hours. Thereafter, the supernatant was removed, 150 μl of dimethyl sulfoxide was added, shaken for 30 minutes to dissolve the generated formazan, and absorbance was measured at 540 nm using a multimicroplate reader (Molecular device Spectra max190). Cell viability was calculated according to the formula below, and the results are shown in Table 6 below.
세포생존율(%)=시료첨가군의 흡광도/대조군의흡광도 × 100Cell viability (%) = absorbance of sample added group / absorbance of control group × 100
상기 표 6에서 확인되는 바와 같이 시료 모두 세포 독성에는 영향을 미치지 않는 것으로 확인되었고, 이에 안전에는 문제가 없는 것을 확인하였다.As confirmed in Table 6, it was confirmed that all samples did not affect cytotoxicity, and thus there was no problem with safety.
시험예 3 : 히알루론산 합성효소(HAS-3)의 발현 증가효과 확인Test Example 3: Confirmation of the effect of increasing the expression of hyaluronic acid synthase (HAS-3)
인간 섬유아세포 NHDF를 10% FBS가 첨가된 DMDM 배지를 이용하여 5×105 cell/well로 조절한 후 12 well plate에 접종하고 18시간 동안 배양하였다. 배양한 뒤 상기 실시예 6~8, 비교예 1의 시료를 처리하고 24시간 동안 배양하였다. 배양된 세포에서 RNA를 추출하여 Reverse transcription polymerase chain reaction(RT-PCR)을 통해 Hyaluronan Synthase-3(HAS-3)의 발현 증가율을 확인하였다. HAS-3 발현 증가율은 하기 식에 의해 산출되었고, 그 결과는 표 7에 나타내었다. 대조군으로는 히알루론산(Hyaluronic Acid)을 사용하였다.Human fibroblast NHDF was adjusted to 5×10 5 cells/well using DMDM medium supplemented with 10% FBS, and then inoculated into a 12 well plate and cultured for 18 hours. After culturing, the samples of Examples 6 to 8 and Comparative Example 1 were treated and cultured for 24 hours. RNA was extracted from the cultured cells and the increase in expression of Hyaluronan Synthase-3 (HAS-3) was confirmed through reverse transcription polymerase chain reaction (RT-PCR). The HAS-3 expression increase rate was calculated by the following formula, and the results are shown in Table 7. As a control, hyaluronic acid was used.
HAS-3 발현증가율(%)=(시료 HAS-3 발현양/대조군 HAS-3 발현양) × 100HAS-3 expression increase rate (%) = (sample HAS-3 expression amount / control group HAS-3 expression amount) × 100
상기 표 7에서 확인되는 바와 같이 상기 실시예 6 내지 실시예 8의 복합물에서 실시예 1 내지 5의 혼합물, 제조예 4의 효소처리 멕시칸 치아씨 추출물(표 4)이나, 효소처리하지 않은 멕시칸 치아씨 추출물을 사용한 복합물인 비교예 1에 비하여 우수한 히알루론산 합성효소(HAS-3)의 발현 증가효과를 확인할 수 있었다. 특히 실시예 8의 복합물은 대조군인 히알루론산(Hyaluronic Acid)과 동등한 정도의 발현 증가효과를 나타내었다.As shown in Table 7, in the composites of Examples 6 to 8, the mixture of Examples 1 to 5, the enzyme-treated Mexican chia seed extract of Preparation Example 4 (Table 4), or the non-enzyme-treated Mexican chia seeds Compared to Comparative Example 1, which is a composite using the extract, it was confirmed that the effect of increasing the expression of hyaluronic acid synthetase (HAS-3) was excellent. In particular, the complex of Example 8 exhibited an effect of increasing expression equivalent to that of the control hyaluronic acid.
시험예 4: 히알루로니다제의 활성 억제 효과 확인Test Example 4: Confirmation of the activity inhibitory effect of hyaluronidase
히알루로니다제 활성억제 효과는 모르간-엘손(Morgan-Elson)법을 응용하여 다음과 같이 확인하였다. 히알루로니다제의 최종 효소 활성을 400 NF unit/㎖, HA의 최종농도를 0.4 ㎎/㎖로 하고 활성제인 Compound 48/80 완충(buffer) 용액 (0.1 ㎎/㎖)을 사용하여 불활성형 히알루로니다제의 활성화 단계의 저해작용을 중심으로 히알루로니다제 활성을 측정하였다. 시료는 완충용액 (buffer)에 용해하여 시료 용액으로 하고 대조군은 시료 용액 대신에 완충 용액을 사용하였다. 대조군으로는 히알루론산(Hyaluronic Acid)을 사용하였다. 히아루로니다아제의 활성 저해율(%)은 아래의 수학식으로 계산하였으며, 그 결과는 표 8에 나타내었다.The effect of inhibiting hyaluronidase activity was confirmed as follows by applying the Morgan-Elson method. The final enzyme activity of hyaluronidase was 400 NF unit/ml, the final concentration of HA was 0.4 mg/ml, and the active compound 48/80 buffer solution (0.1 mg/ml) was used to prepare inactive hyaluronic acid. Hyaluronidase activity was measured focusing on the inhibition of the activation step of the enzyme. The sample was dissolved in a buffer solution to form a sample solution, and the control group used the buffer solution instead of the sample solution. As a control, hyaluronic acid was used. The activity inhibition rate (%) of hyaluronidase was calculated by the following formula, and the results are shown in Table 8.
히알루로니다제 활성 저해율(%)=[(A-B)/A]×100Hyaluronidase activity inhibition rate (%) = [(A-B) / A] × 100
A : 시료를 첨가하지 않은 웰의 효소 활성A: Enzyme activity of wells to which no sample was added
B : 시료를 첨가한 웰의 효소 활성B: enzyme activity of the well to which the sample was added
실시예 6 내지 8의 복합물에서 실시예 1 내지 5의 혼합물이나, 제조예 4의 효소처리 멕시칸 치아씨 추출물에 비하여 우수한 히알루로니다제의 활성 억제 효과를 나타내었으며, 이에 따라 혼합에 따른 상승효과를 확인할 수 있었다. 또한 효소처리하지 않은 멕시칸 치아씨 추출물을 사용한 복합물(비교예 1)에 비하여도 우수한 히알루로니다제의 활성 억제 효과를 확인할 수 있었다.The composites of Examples 6 to 8 exhibited an excellent hyaluronidase activity inhibitory effect compared to the mixtures of Examples 1 to 5 or the enzyme-treated Mexican chia seed extract of Preparation Example 4, and thus the synergistic effect of mixing I was able to confirm. In addition, it was confirmed that the hyaluronidase activity inhibition effect was superior to that of the composite using the Mexican chia seed extract without enzyme treatment (Comparative Example 1).
시험예 5: MMP-1 생성억제효과 확인Test Example 5: Confirmation of MMP-1 production inhibitory effect
인간 정상 피부세포인 섬유아세포(한국 세포주 은행, 대한민국)를 48-웰 마이크로 플레이트(Nunc. 덴마크)에 각 웰 당 1st 106세포가 되도록 접종하고, DMEM 배지(Sigma, 미합중국) 및 37℃의 조건에서 24시간 동안 배양한 후, 상기 제조예 및 실시예의 추출물을 농도가 0.5%, 1.5%, 2%가 되도록 디메틸설폭시드에 희석하여 제조한 희석용액을 첨가한 후 무혈청 DMEM 배지에서 48시간 동안 배양하였다. 배양 후, 각 웰의 상층액을 모아 MMP-1 분석 킷트(Amersham, 미합중국)를 이용하여 새로 합성된 MMP-1의 양(㎍/㎖)을 측정하였다. MMP-1 생성 억제율의 양성 대조군으로 TGF-β(10㎎/㎖, Roche, 미합중국)을 사용하였다. 하기 식에 따라 MMP-1 생성억제율을 계산하였으며, 그 결과는 하기 표 9에 나타내었다.Fibroblasts, which are normal human skin cells (Korea Cell Line Bank, Korea), were inoculated into 48-well microplates (Nunc. Denmark) to be 1st 10 6 cells per well, and DMEM medium (Sigma, United States of America) and 37°C conditions. After incubation for 24 hours, the concentration of the extracts of Preparation Examples and Examples was diluted in dimethyl sulfoxide to a concentration of 0.5%, 1.5%, and 2%, and then diluted solutions were added, followed by serum-free DMEM medium for 48 hours. cultured. After culturing, the supernatant of each well was collected and the amount (μg/ml) of newly synthesized MMP-1 was measured using an MMP-1 assay kit (Amersham, USA). As a positive control for the inhibition of MMP-1 production, TGF-β (10 mg/ml, Roche, USA) was used. The MMP-1 production inhibition rate was calculated according to the following formula, and the results are shown in Table 9 below.
MMP-1 생성억제율(%) = [1-(B/A)] x 100MMP-1 production inhibition rate (%) = [1-(B/A)] x 100
A : 대조군의 MMP-1의 양A: amount of MMP-1 in the control group
B : 실험군의 MMP-1의 양 B: Amount of MMP-1 in the experimental group
(㎍/㎖)sample concentration
(μg/ml)
표 9에서 확인되는 바와 같이 상기 실시예 6 내지 8의 복합물에서 실시예 1 내지 5의 혼합물이나, 제조예 4의 효소처리 멕시칸 치아씨 추출물에 비하여 우수한 MMP-1 생성 억제효과를 나타내었으며, 실시예 8에서 가장 우수한 MMP-1 생성 억제효과를 나타내었다.As confirmed in Table 9, the composites of Examples 6 to 8 exhibited an excellent inhibitory effect on MMP-1 production compared to the mixtures of Examples 1 to 5 or the enzyme-treated Mexican chia seed extract of Preparation Example 4. 8 showed the best MMP-1 production inhibitory effect.
시험예 6: 콜라겐 생합성 촉진 효과 확인Test Example 6: Confirmation of collagen biosynthesis promoting effect
섬유아세포를 10% FBS를 첨가한 IMDM 배지에 5×105의 세포농도로 접종하여 37℃, 5% CO2배양기에서 24시간 동안 배양하였다. 24시간 배양하여 상기 제조예 및 실시예의 추출물을 농도가 각각 0.5, 1.0 및 2.0%가 되도록 디메틸설폭시드에 희석하여 제조한 희석용액을 첨가하여 18시간 동안 동일 조건에서 배양 후 1시간 동안 UV를 조사시켜 세포에 스트레스를 주었다. 이후 Trizol reagent(invitrogen, USA)를 이용하여 섬유아세포를 회수하여 mRNA를 추출하여 일련의 과정을 거쳐 cDNA를 합성하였다. 합성된 cDNA로부터 PROCOLLAGEN TYPEⅠ유전자 부위를 증폭시켜 전기영동을 통해 유전자 발현양을 확인하였으며, 유전자 증폭은 thermal cycler(GenePro, Hangzhou bioer tech., CHINA)를 사용하여 10x taq polymerase buffer, 10 mM dNTP, 10 pmol primer (F: AGC CAG CAG ATC GAG AAC AT, R: TCT TGT CCT TGG GGT TCT TG), taq polymerase를 혼합하고 증류수를 더하여 50 uL로 조정 후 95도 5분 1cycle/95도 1분/51도 2분/72도 1분 28 cycle 증폭, 72도에서 5분간 반응하는 조건으로 수행하였다. 생성된 procollagen의 발현율은 하기 식에 따라 계산하였으며, 대조군으로는 시료를 처리하지 않고 UV를 조사하지 않은 정상 섬유아세포를 사용하였다.Fibroblasts were inoculated at a cell concentration of 5×10 5 in IMDM medium supplemented with 10% FBS, and cultured for 24 hours in a 37° C., 5% CO 2 incubator. After culturing for 24 hours, dilute solutions prepared by diluting the extracts of Preparation Examples and Examples in dimethyl sulfoxide to a concentration of 0.5, 1.0, and 2.0%, respectively, were added, cultured under the same conditions for 18 hours, and then irradiated with UV for 1 hour. to stress the cells. Thereafter, fibroblasts were recovered using Trizol reagent (Invitrogen, USA), mRNA was extracted, and cDNA was synthesized through a series of processes. The PROCOLLAGEN TYPE I gene region was amplified from the synthesized cDNA, and the gene expression level was confirmed through electrophoresis. Gene amplification was performed using a thermal cycler (GenePro, Hangzhou bioer tech., CHINA) in 10x taq polymerase buffer, 10 mM dNTP, 10 Mix pmol primer (F: AGC CAG CAG ATC GAG AAC AT, R: TCT TGT CCT TGG GGT TCT TG) and taq polymerase, add distilled water to adjust to 50 uL, and 95 degrees 5 minutes 1 cycle/95 degrees 1 minute/51 degrees 2 minutes / 72 degrees 1 minute 28 cycle amplification, was carried out under the condition of reacting at 72 degrees for 5 minutes. The expression rate of the produced procollagen was calculated according to the following formula, and as a control group, normal fibroblasts not treated with UV light were used.
procollagen 발현율(%) = B/A x 100procollagen expression rate (%) = B/A x 100
A: 상기 대조군에서의 procollagen 발현 양A: the amount of procollagen expression in the control group
B: 시료 처리 및 UV조사 섬유아세포의 procollagen 발현 양B: amount of procollagen expression in sample treatment and UV-irradiated fibroblasts
표 10에서 확인되는 바와 같이 상기 실시예 6 내지 8의 복합물에서 우수한 콜라겐 생합성 촉진 효과를 나타냄을 확인할 수 있었고, 실시예 8의 복합물 시료에서 특히 우수한 콜라겐 생합성 촉진 효과를 나타냄을 확인할 수 있었다.As confirmed in Table 10, it was confirmed that the composites of Examples 6 to 8 exhibited an excellent collagen biosynthesis promoting effect, and the composite sample of Example 8 exhibited a particularly excellent collagen biosynthesis promoting effect.
제형 실시예 1: 스킨로션의 제조Formulation Example 1: Preparation of skin lotion
하기 표 11의 조성에 따라, 통상의 방법으로 본 발명 실시예의 복합물을 함유한 스킨로션 1kg을 제조하였다.According to the composition of Table 11 below, 1 kg of skin lotion containing the complex of the examples of the present invention was prepared in a conventional manner.
제형 실시예 2: 영양로션의 제조Formulation Example 2: Preparation of nutritional lotion
하기 표 12의 조성에 따라, 통상의 방법으로 본 발명 실시예의 복합물을 함유한 영양로션 1kg을 제조하였다.According to the composition of Table 12 below, 1 kg of nutritional lotion containing the complex of Examples of the present invention was prepared in a conventional manner.
시험예 7: 제형안정도 확인Test Example 7: Confirmation of Formulation Stability
상기 제형 실시예에서 제조한 제형에 대하여 실온(25℃), 냉장(4℃) 및 항온(50℃)으로 일정하게 유지되는 실내, 냉장고 및 인큐베이터에서 불투명 초자 용기에 담아 12주 동안 보관 및 관찰(변색, 변취 및 분리)하며, 안정성을 확인 하였다. 결과는 표 13에 나타내었다. Storage and observation for 12 weeks ( discoloration, odor and separation), and stability was confirmed. The results are shown in Table 13.
< 제형 안정 등급 ><Formulation Stability Grade>
0: 변화 없음 1: 미세한 변화 2: 변화 3: 극심한 변화0: No change 1: Minor change 2: Change 3: Extreme change
상기 표 13에서 확인되는 바와 같이, 바이오셀룰로오스 분말을 함유하는 스킨로션 및 영양로션의 제형에서 12주간의 보관에도 변색, 변취 및 분리가 나타나지 않아 안정성이 우수한 것을 알 수 있다.As confirmed in Table 13, it can be seen that the formulation of the skin lotion and nutrient lotion containing the biocellulose powder did not show discoloration, odor, or separation even after 12 weeks of storage, indicating excellent stability.
Claims (6)
The cosmetic composition according to claim 1, wherein the cosmetic composition is for improving skin wrinkles.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220021009A KR20230123790A (en) | 2022-02-17 | 2022-02-17 | Cosmetic composition containing bio-cellulose |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220021009A KR20230123790A (en) | 2022-02-17 | 2022-02-17 | Cosmetic composition containing bio-cellulose |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230123790A true KR20230123790A (en) | 2023-08-24 |
Family
ID=87841557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220021009A KR20230123790A (en) | 2022-02-17 | 2022-02-17 | Cosmetic composition containing bio-cellulose |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20230123790A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170060744A (en) | 2015-11-25 | 2017-06-02 | (주)제주사랑농수산 | Cosmetic Composition Using Bio-Cellulose and 1,3-butylene glycol |
KR101745326B1 (en) | 2017-04-05 | 2017-06-13 | (주) 본느 | Cosmetic composition comprising biocellulose powder and method for manufacturing the same |
-
2022
- 2022-02-17 KR KR1020220021009A patent/KR20230123790A/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170060744A (en) | 2015-11-25 | 2017-06-02 | (주)제주사랑농수산 | Cosmetic Composition Using Bio-Cellulose and 1,3-butylene glycol |
KR101745326B1 (en) | 2017-04-05 | 2017-06-13 | (주) 본느 | Cosmetic composition comprising biocellulose powder and method for manufacturing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4693623B2 (en) | Cosmetics | |
KR101321854B1 (en) | Cosmetic composition containing fucus vesiculosus extract and prunella vulgaris extract for improving skin wrinkle and elasticity | |
CN108245479B (en) | Facial mask containing bifidobacterium lactis fermented active extract | |
KR20110009652A (en) | Extract produced from orchid family plant, method for production thereof and prepartion for external application to skin comprising extract produced from orchid family plant | |
KR101895412B1 (en) | A functional cosmetic composition for skin whitening comprising natural complex extract | |
CN106880561B (en) | Cosmetic composition containing black bamboo extract for regulating skin temperature | |
KR101686112B1 (en) | Composition of culture medium for cultivation of Lactobacillus, ginseng berry-fermented extracts comprising thereof and cosmetic composition for improving skin conditions | |
KR101375137B1 (en) | A cosmetic composition comprising fermented extract of Scutellaria baicalensis using Leatiporus sulphureus var. miniatus for skin moisturizing | |
KR101987167B1 (en) | Cosmetic composition for improving skin hydration and skin barrier function | |
KR20190063549A (en) | Cosmetic Composition Comprising Bamboo Fermented Extract | |
KR101582974B1 (en) | Composition for improving skin condition containing the complex extracts of Hydrolyzed Manihot Esculenta Tuber and Chrysanthemum Parthenium | |
JP2022049690A (en) | Novel aureobasidium pullulans strain and use thereof | |
JP5483928B2 (en) | Cosmetics | |
JP2023171950A (en) | Anti-aging agent, antioxidant, anti-inflammatory agent, and whitening agent, as well as cosmetic | |
KR102441009B1 (en) | Methods for extracting compound from ginseng, ginseng extract comprising the compound and composition for enhancing skin barrier comprising the same | |
KR102477052B1 (en) | Skin external composition containing a proteinpolysaccharide or oligo collagen peptide derived from an inula flower and the method for preparing the same | |
KR101960571B1 (en) | Method for preparing apricot extract, the apricot extract prepared therefrom, and skin care or cosmetic composition comprising the apricot extract | |
KR20230123790A (en) | Cosmetic composition containing bio-cellulose | |
KR102308756B1 (en) | Cosmetic Composition Containing Mixture Extracts of Citrus Unshiu Peel Extract and Andrographis Paniculata As Active Ingrediend | |
KR102119622B1 (en) | Cosmetic composition comprising the extract of fermented Sorghum Bicolor sprout for skin anti-wrinkle effect and producing method thereof | |
KR20170005534A (en) | The Cosmetic composition containing the culture medium of mycelium from Elfvingia applanata using natural medium | |
CN111407702A (en) | Skin-care face cream containing sophora flower and seaweed and preparation method of skin-care face cream | |
KR102615332B1 (en) | Cosmetic composition comprising Feverfew extract | |
KR102581571B1 (en) | Cosmetic composition containing the mixed extract of Polygonum aviculare, Poncirus trifoliata fruit and Hovenia dulcis fruit | |
KR102453167B1 (en) | Cosmetic composition for improving skin containing phyto-ceramide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal |